News

Bozeman, Montana’s SiteOne Therapeutics working on alternative opioid treatment receives $1 million grant

November 8, 2017 /

MATR Sponsor (view all)


"For small to medium to national organizations, for events and fundraisers of any size, in any format – live, virtual or hybrid – the platform is built for scale."

A Bozeman biotech company announced Tuesday it received a $1 million federal grant to continue its work developing a pain medication alternative to opioids.

The company, SiteOne Therapeutics https://www.siteonetherapeutics.com/ , is currently developing a drug that effectively blocks pain signals to the brain. SiteOne’s founders have said the treatment would be a welcome alternative to opioid painkillers such as oxycodone and fentanyl, which have adverse side effects including dependency and addiction.

The grant money was awarded through an R&D arm of the U.S. Department of Defense.

By Lewis Kendall Chronicle Staff Writer

https://www.bozemandailychronicle.com/news/business/tech-company-working-on-alternative-opioid-treatment-receives-million-grant/article_d7ef6d79-49b7-53a0-a5cb-271d6e8aa345.html

MATR Supporters (view all)


Prospera helps businesses and communities find their pathway to success, acting as the navigator, problem solver and catalyst for a strong Montana economy.

SBA 504 Loans offered statewide! Real estate and equipment, acquisitions, renovation, and new construction. Low, fixed-rates up to 25 years with as little as 10% down.

For over 25 years, Montana World Trade Center® has served Montana as a trusted business adviser.
Posted in:

Sorry, we couldn't find any posts. Please try a different search.

Leave a Comment

You must be logged in to post a comment.